John Yogi Spence - 01 Sep 2026 Form 4 Insider Report for Evanston Multi-Alpha Fund

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Sep 2026, 13:02:16 UTC
Prior SEC filing
17 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
John Yogi Spence

Key filing fact

John Yogi Spence filed Form 4 for Evanston Multi-Alpha Fund on 03 Sep 2026.

Key facts

  • This page summarizes John Yogi Spence's Form 4 filing for Evanston Multi-Alpha Fund.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Sep 2026, 13:02.

Change

  • Previous filing in this sequence was filed on 17 Aug 2026.
  • Current net transaction value: +$100,001.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001718133 Primary reporting owner

Spence John Yogi

Relationship
Vice President
Address
321 N. CLARK STREET, CHICAGO
Signature
John Yogi Spence
Signature date
03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Class I Shares of Beneficial Ownership

Purchase

Transaction value
$100,001
Shares
+10,388
Change %
Price
$9.63
Shares after
10,388
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Class I Shares of Beneficial Ownership were acquired at net asset value pursuant to the Fund's continuous offering. The Fund is a non-traded, closed-end fund that does not list its shares on any securities exchange, and shares are issued at the per-share net asset value as of the date on which the subscription is accepted.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .